Equipment House profit down 77% to SAR 17.6 million in 2022; Q4 loss at SAR 25.3 mln
View other reports
Scientific & Medical Equipment House Co. reported a net profit after minorities of SAR 17.6 million for 2022, a decline of 77% from SAR 77.5 million a year before.
Financials (M)
| Item | 2021 | 2022 | Change |
|---|---|---|---|
| Revenues | 699.45 | 713.82 | 2.1 % |
| Gross Income | 152.98 | 154.85 | 1.2 % |
| Operating Income | 83.42 | 37.51 | (55.0 %) |
| Net Income | 77.52 | 17.57 | (77.3 %) |
| Average Shares | 30.00 | 30.00 | - |
| EPS (Riyals) | 2.58 | 0.59 | (77.3 %) |
Gross profit ratio settled at 21.7% in 2022, while operating income, before provision for expected credit loss, fell 12.5% year-on-year (YoY) to SAR 76.9 million.
Finance costs reached SAR 7.0 million due to significant interest rate hikes in 2022, and Zakat provision amounted to SAR 4.0 million.
Current Quarter Comparison (M)
| Item | Q4 2021 | Q4 2022 | Change |
|---|---|---|---|
| Revenues | 205.30 | 188.89 | (8.0 %) |
| Gross Income | 39.07 | 34.08 | (12.8 %) |
| Operating Income | 17.52 | (22.44) | (228.1 %) |
| Net Income | 17.45 | (25.31) | (245.0 %) |
| Average Shares | 30.00 | 30.00 | - |
| EPS (Riyals) | 0.58 | (0.84) | (245.0 %) |
The company incurred a loss of SAR 25.3 million in Q4 2022, against a profit of SAR 17.4 million a year before.
Sequentially, the company turned to a loss in Q4 2022 from a profit of SAR 8.79 million.
Shareholders’ equity, after minority interest, stood at SAR 470.3 million as of Dec. 31, 2022, compared to SAR 473.4 million a year earlier.
Financial results (Million)
| Period | Revenues | Change | Gross Income | Change | Net Income | Change | EPS(Riyal) |
|---|---|---|---|---|---|---|---|
| Q1 2022 | 162.56 | 7.3 % | 37.92 | 16.1 % | 16.73 | (12.8 %) | 0.56 |
| Q2 2022 | 176.30 | 6.1 % | 46.82 | 7.1 % | 17.36 | (27.4 %) | 0.58 |
| Q3 2022 | 186.07 | 5.4 % | 36.03 | (4.0 %) | 8.79 | (48.2 %) | 0.29 |
| Q4 2022 | 188.89 | (8.0 %) | 34.08 | (12.8 %) | (25.31) | (245.0 %) | (0.84) |
| 2022 | 713.82 | 2.1 % | 154.85 | 1.2 % | 17.57 | (77.3 %) | 0.59 |
Profitability
| Period | Gross Margin | OIBDA Margin | Net Margin Before Unusual Items |
|---|---|---|---|
| Q1 2022 | 22.27 % | 14.03 % | 10.57 % |
| Q2 2022 | 22.39 % | 13.20 % | 9.51 % |
| Q3 2022 | 21.89 % | 12.78 % | 8.26 % |
| Q4 2022 | 21.69 % | 7.64 % | 2.46 % |
| 2022 | 21.69 % | 7.64 % | 2.46 % |
Per Share Data (Riyal)
| Period | Shares Outstanding (M) | EPS (Riyal) | Adjusted EPS (Riyal) | Book Value (BV) |
|---|---|---|---|---|
| Q1 2022 | 30.00 | 2.50 | 2.50 | 16.34 |
| Q2 2022 | 30.00 | 2.28 | 2.28 | 16.25 |
| Q3 2022 | 30.00 | 2.01 | 2.01 | 16.54 |
| Q4 2022 | 30.00 | 0.59 | 0.59 | 15.68 |
Multiple Ratios (End of Period Price)
| Period | P/E | Adjusted P/E | Price/book |
|---|---|---|---|
| Q1 2022 | 21.32 | 21.32 | 3.27 |
| Q2 2022 | 18.98 | 18.98 | 2.67 |
| Q3 2022 | 21.69 | 21.69 | 2.64 |
| Q4 2022 | 69.58 | 69.58 | 2.60 |
Business Segments (Million)
Q4 2022
| Period | Operation and maintenance | Sales of medical devices and revenue from after-sales maintenance services | Construction | Medications and Medical Supplies | Meat and Food | Eliminations |
|---|---|---|---|---|---|---|
| Q1 2022 | 130.15 | 11.47 | 11.04 | 8.94 | 3.48 | (2.51) |
| Q3 2022 | 144.11 | 11.32 | 15.37 | 14.70 | 1.19 | (0.62) |
| Q4 2022 | 142.97 | 27.07 | 26.12 | (5.58) | 0.97 | (2.66) |
| Current | |
| Market Cap (M Riyal) | 1,533.00 |
| Enterprise Value (EV) (M) | 1,754.95 |
| Shares Outstanding ((M)) | 30.00 |
| EPS ( Riyal) (TTM) | 1.40 |
| Book Value (BV) ( Riyal) | 17.32 |
| Par Value ( Riyal) | 10.00 |
| Adjusted P/E (Last12) | More than 100 |
| P/E (TTM) | 36.53 |
| Price/book | 2.95 |
| Return on Average Assets (%) (TTM) | 4.0 |
| Return on Average Equity (%) (TTM) | 8.4 |
Comments {{getCommentCount()}}
Be the first to comment
رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}
{{comment.DisplayName}}
{{comment.ElapsedTime}}